IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.
If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!
Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.
Company: Grupo Financiero Galicia S.A.
Symbol: GGAL
Price: Last Trade $46.29
Trade Date: 9/27
Shares: 13.4 million
Underwriter(s) : BofA Merrill Lynch, UBS
Rating = Subscription Needed
Company: BioCryst Pharmaceuticals, Inc.
Symbol: BCRX
Price: Last Trade $5.75
Trade Date: 9/13
Shares: 13.9 million ($80m cash raise)
Underwriter(s) : J.P. Morgan, Barclays
Rating = Subscription Needed
Company: Portola Pharmaceuticals
Symbol: PTLA
Price: Last Trade $55.71
Trade Date: 9/13
Shares: 5.4 million ($300m cash raise)
Underwriter(s) : Morgan Stanley, Citigroup, Goldman Sachs
Co-Manager(s): Cowen & Company, William Blair
Rating = Subscription Needed
Company: Camden Property Trust – Block
Symbol: CPT
Price: Last Trade $94.92
Trade Date: 9/12
Re-Offer Range: Subscription Needed
Shares: 4.75 million
Underwriter(s) : Deutsche Bank Securities, J.P. Morgan
Rating = Subscription Needed
Company: First Data Corporation
Symbol: FDC
Price: Last Trade $18.85
Trade Date: 9/14
Shares: 85 million
Underwriter(s) : BofA Merrill Lynch, Citigroup, KKR
Co-Manager(s): PNC Capital Markets, Wells Fargo, Credit Suisse, Deutsche Bank, Goldman Sachs & Co., HSBC, Mizuho Securities, Morgan Stanley, SunTrust Robinson Humphrey, Keefe Bruyette & Woods, KeyBanc Capital
Rating = Subscription Needed